Credence Genomics Sri Lanka’s first and only NGS based diagnostic firm made Sri Lanka proud again by reaching the finals of Pitch@Palace Commonwealth held at St. James’s Palace, London as part of the Commonwealth.
Credence Genomics were in the Top 5 in the People’s Choice category and among the final 12 as well.
Pitch@Palace Commonwealth is the platform to showcase Entrepreneurs from the 53 Commonwealth countries and it supports entrepreneurs by connecting them to local and international networks, thus helping them to amplify their businesses.
It is an opportunity for entrepreneurs from each of the 53 Commonwealth countries to pitch their business to CEOs, Influencers, Angels, Mentors and potential Investors and Business Partners. The Summit’s theme is ‘Towards a common future’ and is focused on building on the strengths of the Commonwealth to ensure responsiveness to global challenges and delivery of a more prosperous, secure, sustainable and fair future for all Commonwealth citizens.
Credence Genomics a new genetic mapping and diagnostics start up from Sri Lanka, already recognized globally for their innovative diagnostics using cutting edge technology, represented Sri Lanka under Biotech and Medtech at pitch@palace Commonwealth, making them the first ever applicant from Sri Lanka for the most prestigious Pitch@ Palace host by the Duke of the York and the Royal Family. Conceived by Dr. Vaz Gnanam in 2011 Credence Genomics was one of the earliest biotechnology startups not only in Sri Lanka but the region to invest in cutting edge NGS and application development.
Steering the clinical genomics initiative, he led a team of scientists and ICT engineers to develop leading edge innovative diagnostics tests which have been the result of 6 years of stringent research on industry defining genetic science, application of information technology and testing across a broad spectrum of diseases.
0 comments: